Skip to main content
SpringerLink
Log in

Therapieoptimierung bei diabetischer Nephropathie

AVOID-Studie („Aliskiren in the evaluation of proteinuria in diabetes“)

Optimal therapy of diabetic nephropathy: AVOID Study (Aliskiren in the evaluation of proteinuria in diabetes)

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Lea J, Greene T, Hebert L et al. (2005) The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med 165: 947–953

    Article  PubMed  Google Scholar 

  2. Mann JF, Schmieder RE, McQueen M et al. (2008) for the ONTARGET investigators Renal outcomes with telmisartan, ramipril or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372: 547–553

    Article  PubMed  CAS  Google Scholar 

  3. Schmieder RE, Schrader J, Zidek W et al. (2007) Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 96: 247–257

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin:

Der Autor, Prof. Dr. Roland E. Schmieder, ist als Referent für mehrere pharmazeutische Firmen, die Medikamente zur Therapie der diabetischen Nephropathie herstellen, tätig (Novartis, MSD, BMS, Boehringer Ingelheim, AstraZeneca). Der Autor ist ferner Projektleiter im SFB 423 Niere mit dem Thema: Diabetische Nephropathie.

Author information

Authors and Affiliations

  1. Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen, Krankenhausstraße 12, 91054, Erlangen, Deutschland

    R.E. Schmieder

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. R.E. Schmieder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R.E. Schmieder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmieder, R., Nitschmann, S. Therapieoptimierung bei diabetischer Nephropathie. Internist 50, 895–896 (2009). https://doi.org/10.1007/s00108-009-2391-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-009-2391-1

Search

Navigation